News

HD IL-2 therapy is administered in specialized hospitals as inpatient therapy while vemurafenib as an oral outpatient therapy. Conducted in approximately 25 sites in the US, the Phase

Revenues for the second quarter ended 31 March 2013 were $50.04m compared to $39.92m for the second quarter ended 31 March 2012. Net income for the first six

ATMI will supply disposable manufacturing process for the expansion of patient’s liver cells outside of the body, a step vital in converting a patient’s own liver cells into

Phytofare Catechin Extract offers meaningful disease prevention from a compromised immune system, infections, viruses, malaria and other parasitic infections. Research has shown that green tea gallate catechins are

The recombinant topical thrombin is indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard

Pertzye, the pancreatic enzyme product, is indicated for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF). DCI earlier marketed the Pertzye formulation under

As per the terms of the equity transfer and exclusive license agreement, Nordic has agreed to pay $1,000,000 for Unigene’s ownership interest in the JDV. As part of

The expansion, which is a key part of the 2013 strategic plan, is expected to support the increasing demand for the company’s products and services. The global payment

Adasuve (loxapine) inhalation powder is indicated for the acute treatment of agitation coupled with schizophrenia and bipolar I disorder. Under the US license and supply agreement, Teva will